AYTU · Categories · Form 4

AYTU - SEC Form 4 insider transactions

Aytu BioPharma Inc. (AYTU) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AYTU

• 239d
  Chief Commercial Officer Pyszczymuka Greg was granted 12,500 shares, increasing direct ownership by 53% to 36,102 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Chief Business Officer Disbrow Jarrett was granted 32,106 shares, increasing direct ownership by 109% to 61,568 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Chief Financial Officer Selhorn Ryan J was granted 33,743 shares, increasing direct ownership by 211% to 49,743 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Chief Executive Officer Disbrow Joshua R. was granted 53,946 shares, increasing direct ownership by 35% to 207,203 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Director Liu Vivian H was granted 10,000 shares, increasing direct ownership by 102% to 19,825 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Director Jain Abhinav was granted 10,000 shares, increasing direct ownership by 105% to 19,500 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Director Dockery Carl was granted 10,000 shares, increasing direct ownership by 96% to 20,440 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 239d
  Director Donofrio John Jr. was granted 10,000 shares, increasing direct ownership by 266% to 13,762 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 359d
  SEC Form 4 filed by Large owner Nantahala Capital Management, Llc

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 429d
  Chief Commercial Officer Pyszczymuka Greg converted options into 209 shares, increasing direct ownership by 0.89% to 23,602 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 457d
  Chief Financial Officer Selhorn Ryan J converted options into 105 shares, increasing direct ownership by 0.66% to 16,000 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 517d
  Chief Commercial Officer Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.90% to 23,393 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 567d
  Chief Financial Officer Selhorn Ryan J was granted 14,000 shares, increasing direct ownership by 739% to 15,895 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  Director Dockery Carl was granted 1,500 shares, increasing direct ownership by 17% to 10,440 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  Director Donofrio John Jr. was granted 1,500 shares (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  Director Jain Abhinav was granted 1,500 shares, increasing direct ownership by 19% to 9,500 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  SEC Form 4 filed by Chief Executive Officer Disbrow Joshua R.

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  SEC Form 4 filed by Chief Business Officer Disbrow Jarrett

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  Director Liu Vivian H was granted 1,500 shares, increasing direct ownership by 18% to 9,825 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  Amendment: Director Liu Vivian H was granted 1,500 shares, increasing direct ownership by 22% to 8,325 units (SEC Form 4)

  4/A - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 572d
  SEC Form 4 filed by Chief Commercial Officer Pyszczymuka Greg

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 609d
  Chief Commercial Officer Pyszczymuka Greg converted options into 209 shares, increasing direct ownership by 0.91% to 23,185 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 701d
  Chief Commercial Officer Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.91% to 22,976 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 715d
  SEC Form 4 filed by Large owner Nantahala Capital Management, Llc

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 792d
  Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.92% to 22,768 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 883d
  Pyszczymuka Greg converted options into 209 shares, increasing direct ownership by 0.94% to 22,560 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 974d
  Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.94% to 22,351 units (SEC Form 4)

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1020d
  SEC Form 4: Jain Abhinav was granted 6,500 shares, increasing direct ownership by 433% to 8,000 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4 filed by Disbrow Jarrett

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4: Jain Abhinav was granted 1,500 shares

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4: Liu Vivian H was granted 1,500 shares, increasing direct ownership by 440% to 1,841 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4: Donofrio John Jr. was granted 1,500 shares, increasing direct ownership by 197% to 2,262 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4: Dockery Carl was granted 1,500 shares, increasing direct ownership by 20% to 8,940 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4 filed by Disbrow Joshua R.

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4 filed by Brooke Christopher

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4 filed by Oki Mark K

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1023d
  SEC Form 4 filed by Pyszczymuka Greg

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1063d
  SEC Form 4 filed by Pyszczymuka Greg

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1079d
  SEC Form 4 filed by Pyszczymuka Greg

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1079d
  SEC Form 4 filed by Pyszczymuka Greg

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1084d
  SEC Form 4 filed by Disbrow Joshua R.

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1209d
  SEC Form 4: Liu Vivian H was granted 6,500 shares, increasing direct ownership by 2,000% to 6,825 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1258d
  SEC Form 4: Donofrio John Jr. returned 187,804 shares to the company, decreasing direct ownership by 92% to 15,267 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1258d
  SEC Form 4: Cantrell Gary returned 40,000 shares to the company, decreasing direct ownership by 20% to 164,089 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1258d
  SEC Form 4: Disbrow Joshua R. returned 80,000 shares to the company, decreasing direct ownership by 6% to 1,151,877 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1258d
  SEC Form 4: Dockery Carl returned 40,000 shares to the company, decreasing direct ownership by 21% to 148,805 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1260d
  SEC Form 4: Disbrow Joshua R. bought $25,047 worth of shares (112,371 units at $0.22), increasing direct ownership by 10% to 1,231,877 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1260d
  SEC Form 4: Pyszczymuka Greg bought $24,480 worth of shares (100,000 units at $0.24), increasing direct ownership by 122% to 182,056 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1283d
  SEC Form 4: Disbrow Joshua R. bought $52,614 worth of shares (222,000 units at $0.24), increasing direct ownership by 25% to 1,119,506 units (Amendment)

  4/A - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1283d
  SEC Form 4: Oki Mark K bought $20,700 worth of shares (90,000 units at $0.23), increasing direct ownership by 90% to 190,000 units (Amendment)

  4/A - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1290d
  SEC Form 4: Disbrow Joshua R. was granted 222,000 shares, increasing direct ownership by 25% to 1,119,506 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1290d
  SEC Form 4: Oki Mark K was granted 90,000 shares, increasing direct ownership by 90% to 190,000 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1433d
  SEC Form 4: Liu Vivian H was granted 6,500 shares

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1596d
  SEC Form 4: Oki Mark K was granted 100,000 shares

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1850d
  SEC Form 4 filed by ARMISTICE CAPITAL, LLC

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1874d
  SEC Form 4: DOCKERY CARL was granted 187,804 units of Common Stock, increasing direct ownership by 18,762% to 188,805 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1874d
  SEC Form 4: MACALUSO MICHAEL was granted 187,804 units of Common Stock, increasing direct ownership by 926% to 208,079 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1874d
  SEC Form 4: Donofrio John Jr. was granted 187,804 units of Common Stock, increasing direct ownership by 1,230% to 203,071 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1874d
  SEC Form 4: Cantrell Gary was granted 187,804 units of Common Stock, increasing direct ownership by 1,153% to 204,089 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
• 1874d
  SEC Form 4: Disbrow Joshua R. was granted 800,000 units of Common Stock, increasing direct ownership by 820% to 897,506 units

  4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)

Other AYTU categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends